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Abstract 
cDNA generated from stimulated abomasal lymph node cells was used to amplify and clone the 35 kDa and 40 kDa subunits of bovine 
interleukin 12 (IL-12) using primers derived from semi-conserved regions between human and mouse IL-12 sequences. The deduced 
amino acid sequence of the 40 kDa subunit demonstrated 84.4% and 67.6% homology with human and mouse sequences, respectively. 
The deduced sequence of the 35 kDa subunit exhibited comparable similarities to the human 35 kDa subunit (82.2%) but differed 
significantly (58.6%) from mouse-derived sequences. 
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Interleukin 12 (IL-12), formerly called cytoxic lympho- 
cyte maturation factor and natural killer cell stimulatory 
factor [1,2], is a glycosylated, 75 kDa heterodimeric cy- 
tokine comprised of disulfide-bonded 35 kDa and 40 kDa 
subunits. IL-12 synergistically facilitates the induction of 
cytolytic T lymphocytes in conjunction with IL-2, and acts 
independently to stimulate growth and differentiation of 
activated T cells. IL-12 also induces interferon-'/ in natu- 
ral killer cells and T cells and, as such, may play a major 
role in cell-mediated immunity directed against a broad 
class of infectious agents and tumors. 
Therapeutic characteristics of IL-12 have been inferred 
from studies with IL-12 treated allergic individuals [3] who 
subsequently exhibited the conversion of mixed T cell 
populations to a predominantly TH1 phenotype and, more 
recently, from its application in tumor regression studies 
[4]. Because of the lack of reagents, however, the role of 
IL-12 in protective immunity in agriculturally important 
animals has not been delineated. The development of such 
reagents will assist in the identification of important im- 
munoregulatory responses against parasitic and other infec- 
tions. Recent research as demonstrated that the generation 
of immunity against some gastrointestinal nematodes i  
strongly influenced by host genetics [5] and that protected 
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animals are better able to maintain proper ratios of T 
lymphocyte subpopulations [6]; consequently, cytokines 
such as IL-12 that significantly affect T cell growth and 
differentiation may influence protective immunity against 
a broad range of infections including parasitic and, more 
importantly, zoonotic diseases. 
The two subunits of IL-12 are encoded by distinct genes 
[7] which, in the mouse model, show differences in their 
sites of mRNA synthesis. Whereas transcription of 40 kDa 
subunit mRNA is limited to lymphoid cells, mRNA from 
the 35 kDa subunit has been found in both lymphoid and 
nonhemopoetic tissues. Coexpression of both subunits is 
required for the generation of a bioactive molecule. An 
interspecific heterodimer c eated from recombinant mouse 
35 kDa [8] and human 40 kDa [7] subunits demonstrated 
bioactivity in mouse cells [8]; however, replacement of the 
mouse 35 kDa subunit with the human homologue abol- 
ished activity in mouse cells. These results illustrate the 
species pecific character of the 35 kDa subunit of human 
IL-12 and suggest hat studies on IL-12 in other animal 
systems will require generating the homologous cytokine. 
In this study, bovine cells isolated from abomasal lymph 
nodes were stimulated in culture in the presence of 2.5 
/zg/ml Concanavalin A (Con A) and 5 ng/ml Phorbol 
12-myristate 13-acetate (PMA). cDNA was synthesized 
from poly A mRNA in the presence of oligo dT and 
Moloney Murine Leukemia Virus reverse transcriptase ac- 
cording to manufacturer's recommendations (Gibco-BRL, 
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Gaithersburg, MD). The primers used for amplification 
included one human primer, #227 (5'CTCCGTCCTGCC- 
CAGAGCAAGATG)  and two bovine primers, #237 
(5 'AAAGGA TCCATGCACCCTCAGCAGTTGGTCG)  
and #238 (5'AAGAAGCTTCTCTGAGGTTTCATACT- 
GAGGT). Primer #227 was derived from the human 40 
kDa subunit located upstream and inclusive of the transla- 
tion start site (Bold). Primers #237 and #238 were de- 
rived from previously cloned partial bovine sequences and 
contained the translation start site (#237) and the 5' termi- 
nus (#238). Primers #237 and #238 were synthesized 
with 5' terminal BamHI  and Hindl I I  restriction enzyme 
sites (underlined), respectively. Because of low product 
yields, amplification of the 40 kDa subunit of bovine IL-12 
required two rounds of PCR using degenerative (37°C), 
followed by specific (55°C), annealing temperatures and 
35 cycles for each amplification. First round amplification 
was performed using primers #227 and #238 and was 
followed by agarose gel fractionation and reamplification 
of the region migrating between 1.0-1.1 kb with nested 
primer #237 and primer #238 which encompassed the 
entire open reading frame. The final product was cloned 
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Fig. 1. (A) Nucleotide sequence ofthe gene encoding the 40 kDa subunit 
of bovine IL-12 (BOIL1240). The underlined bases at the beginning and 
end of the sequence r present the translation start and stop sites as 
predicted from human and mouse sequences. RI ~ EcoRI. (B) Compari- 
son of deduced, IL-12 40 kDa subunit amino acid sequences from bovine 
(Bo) Human (Hu) and mouse (Ms). Dots (. . .)  indicate consensus with 
the bovine sequence; deletions are represented by (-). 
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Fig. 2. (A) Nucleotide sequence ofthe gene ncoding the 35 kDa suhunit 
of bovine IL-12 (BOIL1235). Lower case letters proximal to the transla- 
tion start and stop sites represent human-derived PCR primers used in the 
second round PCR amplification. Underlined fragments depict a highly- 
conserved 41 bp internal repeat. B = BamHI; H = HindlII; RI = EcoRI; 
RV = EcoRV; X = XbaI. (B) Comparison of deduced, IL-12 35 kDa 
amino acid sequences from bovine (Bo), human (Hu) and mouse (Ms). 
Dots (-..) indicate conserved amino acids; deletions are represented by
(-). 
into pUC 18 and several clones were sequenced in both 
directions for verification. 
The 35 kDa subunit also required two rounds of PCR 
using the human primers #260 (5'ACGGTTFGGAGG- 
GACCTC) ,  #234 (5 'GAGACCAGAGTCCCGG-  
GAAAGTC) and #235 (5'CTGCAGTGCCGGCTCAG- 
CATGTG). All three primers were highly conserved within 
the mRNA sequence encoding the mouse IL l2 35 kDa 
subunit. These three sequences corresponded to untrans- 
lated regions of the encoding mRNA sequence which were 
upstream of the translation start site (#260), inclusive of 
the ATG translation start site (Bold) (#235) and down- 
stream but proximal to the translation stop site. The prod- 
ucts amplified with primers #260 and #234 were sepa- 
rated by agarose gel electrophoresis and the region migrat- 
ing at approx. 850 bp was reamplified with the human 
primers #260 and #235. All amplifications were per- 
formed for 35 cycles using a 60°C annealing temperature. 
The resultant product was inserted into the SmaI site of 
pUC 18 and several clones were picked and sequenced. 
As in the case of other bovine lymphokines like IL-2 
and IL-4, the 984 and 666 base pair open reading frames 
of the 40 kDa subunit, designated BOIL1240 (Fig. 1A), and 
the 35 kDa subunit, designated BOIL1235 (Fig. 2A), were 
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more similar to human sequences than to mouse at both 
the DNA and the deduced amino acid levels. BILl240 
showed 87.8% and 75.6% sequence homology with human 
and mouse DNA sequences (data not shown) while ex- 
hibiting 84.4% and 67.6% similarity at the predicted amino 
acid level, respectively (Fig. 1B). A single EcoRI site was 
observed at base 744. The deduced amino acid sequence of 
the 35 kDa subunit exhibited significantly less homology 
with the mouse sequence (58.6%) than with its human 
counterpart (82.2%) with comparable differences observed 
at the DNA level. HindlII, BamHl and XbaI restriction 
enzyme sites were clustered between bases 436 and 468. 
Like the 40 kDa gene, a single EcoRI site was also present 
in the 35 kDa gene at base 614. Within the 35 kDa 
subunit, there exists a 4l bp region extending from base 
283 to base 323 that is repeated between base 325 and 
base 365 and is 80.5% conserved at the DNA level and 
70% conserved at the deduced amino acid level. 
In summary, we have successfully cloned and se- 
quenced the 35 and 40 kDa subunits of bovine 1L-12. The 
availability of the cloned open reading frames will allow 
the construction of specific PCR primers for studying 
IL-12 expression and immune regulatory responses in 
bovine as well as enable the production of an active 
recombinant protein useful in assessing the efficacy of 
IL-12 as a therapeutic treatment against infectious dis- 
eases. 
Nucleotide sequence data reported in this paper have 
been submitted to GenBank TM data base with the acces- 
sion numbers Ul1815 and U14416. 
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